Loading...
NPI 1609889047 · Sykesville, MD · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Sadiq Syed is a retina specialist (ophthalmology) physician provider located in Sykesville, Maryland. This profile covers 19 Medicare and 6 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Sadiq Syed |
| Address | 5963 Exchange Dr |
| City | Sykesville |
| State | MD |
| ZIP | 21784 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | August 15, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.2M |
| Medicaid | $69.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
19 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 960 | $620 | $590.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,240 | $100 | $119.1K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 5,160 | $20 | $118.7K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 1,020 | $90 | $95.7K |
| J2778 | Injection, ranibizumab, 0.1 mg | 410 | $160 | $65K |
| J9035 | Injection, bevacizumab, 10 mg | 750 | $50 | $40.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 300 | $130 | $37.2K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 990 | $30 | $30.6K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 910 | $30 | $26.3K |
| 67210 | The provider destroys a lesion of the retina using a laser beam that heats up the tissue. | 50 | $410 | $22.3K |
Showing 1–10 of 19
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
19 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 48 | 100 | 950 | $690 | $887.3K |
| J2777 | 47 | 70 | 8,520 | $30 | $487.3K |
| J2778 | 37 | 50 | 650 | $180 | $207.8K |
| 67028 | 36 | 120 | 700 | $100 | $101.5K |
| J7312 | 22 | 20 | 270 | $160 | $53.1K |
| 92014 | 83 | 620 | 210 | $90 | $44K |
| 67210 | 4 | 20 | 30 | $430 | $21K |
| 92235 | 27 | 90 | 70 | $110 | $19.5K |
| 92134 | 80 | 490 | 110 | $30 | $17.3K |
| 67108 | 13 | 20 | 20 | $1,010 | $17.2K |
Showing 1–10 of 19
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 440 | $50 | $21.6K |
| J9035 | Injection, bevacizumab, 10 mg | 370 | $50 | $17.1K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 290 | $50 | $13.6K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 240 | $30 | $8.1K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 330 | $20 | $7.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 10 | $160 | $1.9K |
How this provider's Medicaid billing volume and revenue compare to other Maryland providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Maryland median
6 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 16 | 30 | 460 | $40 | $103K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 899 | 930 | 110 | $100 | $90.1K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 37 | 80 | 220 | $30 | $82K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 253 | 430 | 440 | $40 | $59.3K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 42 | 90 | 200 | $30 | $38.9K |
| J9035 | Injection, bevacizumab, 10 mg | 6 | 20 | 190 | $30 | $20.7K |
Other providers in the same ZIP code as Sadiq Syed, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Maryland Treatment Centers Inc | MD | Substance Abuse Rehabilitation Facility | $0 | $10.7M |
| Maryland Treatment Centers Inc | MD | Substance Abuse Rehabilitation Facility | $0 | $7.2M |
| Impact Dui, Ilc | MD | Community/Behavioral Health Agency | $0 | $4.5M |
| Teodora Niculescu | MD | Rheumatology Physician | $602K | $0 |
| Michael Mcevoy | MD | Family Medicine Physician | $472.6K | $0 |
| Wilbur Kuo | MD | Internal Medicine Physician | $315.4K | $0 |
| Scott Buckner | MD | Vascular & Interventional Radiology Physician | $237.2K | $0 |
| Justin Lewis | MD | Foot & Ankle Surgery Podiatrist | $116.9K | $0 |
| Robert Ritchie | MD | Chiropractor | $13K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.